Literature DB >> 4389462

Antiarrhythmic compounds.

L Szekeres, J G Papp.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 4389462     DOI: 10.1007/978-3-0348-7065-8_5

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


× No keyword cloud information.
  7 in total

1.  Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.

Authors:  J Zaagsma; L Meems; M Boorsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  Action of guanethidine on rabbit atrial membranes.

Authors:  Y Misu; H Nishio
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

3.  Cardiac output, heart rate, and blood pressure as influenced by equi-antiarrhythmic doses of eight antifibrillatory agents.

Authors:  O Strubelt; G Back; E Uhl; G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

4.  Mechanism of action of antifibrillatory drugs.

Authors:  P Heistracher
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

5.  Structure and antiarrhythmic activity of three ketophosphonium salts.

Authors:  J P Hénichart; R Houssin
Journal:  Experientia       Date:  1981-03-15

6.  Effect of glucagon on ventricular arrhythmias after coronary artery occlusion and on ventricular automaticity in the dog.

Authors:  B R Madan
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

7.  Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats.

Authors:  Karolina Pytka; Klaudia Lustyk; Elżbieta Żmudzka; Magdalena Kotańska; Agata Siwek; Małgorzata Zygmunt; Agnieszka Dziedziczak; Joanna Śniecikowska; Adrian Olczyk; Adam Gałuszka; Jarosław Śmieja; Anna M Waszkielewicz; Henryk Marona; Barbara Filipek; Jacek Sapa; Szczepan Mogilski
Journal:  Front Pharmacol       Date:  2016-08-03       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.